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Apo =apolipoprotein; HDL-C =HDL-cholesterol; hsCRP =high-sensitivity C-reactive protein; LDL-C =LDL-cholesterol; NS=nonsignificant, P ≥0.05; TG =triglycerides Univariate analysis of prespecified factor subgroups in the mITT population of the VYTAL study cohort (7). Data were analyzed using SAS software (SAS Institute, Inc. Cary, North Carolina). Treatment by subgroup interactions and subgroup effects on the percent changes in efficacy variables were carried out using an ANCOVA model with terms for statin (E/S and A), baseline LDL-C stratum (≥2.59-<3.36, ≥3.36-<4.14, ≥4.14-<4.92, and ≥4.92 mmol/l), and statin-by-subgroup interaction. Estimates of between-treatment group differences, corresponding 95% CIs and p-values were derived from a similar model where statin was replaced by treatment group (E/S 10/20mg vs A10mg, E/S 10/20mg vs A 20mg, or E/S 10/40mg vs A 40mg). *The difference in least-squares means of percent change from baseline at 6 weeks between the highest (second) and lowest (first) subgroup strata for each treatment group was calculated. The minimum and maximum values are presented for the range of calculated differences (see example below). †Proportion of patients attaining LDL-C <1.81 and 2.59 mmol/l assessed by logistic regression analysis. ‡Analyses based on transformed data, using normal scores rank-transformations for TG and hsCRP; § § § § P < 0.001; ║ P < 0.01; ¶ P <0.05 for subgroup effect. #Metabolic syndrome defined as having 3 or more of the following characteristics: 1) Waist Circumference >102 cm (males) or >88 cm (females), 2) TG ≥1.7 mmol/l, 3) HDL-C <1.04 (males) or <1.30 (females) mmol/l, 4) Blood pressure ≥130/85 mmHg or on antihypertensive medication, 5) Fasting glucose ≥5.6 mmol/l or diabetic (2); Conventional unit conversion factors: To convert cholesterol to mg/dl, divide by 0.0259; TG to mg/dl, divide by 0.0113; hsCRP to mg/l, divide by 9.524.
Range for % change in LDL-C by baseline LDL-C strata:
Treatment ≥2.59 -≤3.36 mmol/l ≥4.92mmol/l Difference A 10 -35.6 -40.9 -5.3 A 20 -42.3 -45.7 -3.4 A 40 -50.1 -47.3 2.8 maximum E/S 20 -53.0 -56.8 -3.8 E/S 20 -54.5 -63.2 -8.7 .59 mmol/l related to the continuous (age, BMI, A1C, lipids, hsCRP) and categorical (treatment, race, gender) factors. For example, the coefficient estimate for the treatment effect on LDL-C lowering was -11.28% indicating an 11.28 percentage point larger reduction in LDL-C for patients on ezetimibe/simvastatin versus atorvastatin, while the coefficient for race/ethnicity was 5.49% indicating a 5.49 percentage point smaller reduction in LDL-C for Black/Hispanic subjects compared to Others. †Factors assessed as continuous variables were: age (each 1-yr increase), BMI (each 1-kg/m2 increase); HbA1C (each 1% increase); hsCRP (each 1-nmol/l increase) and LDL-C, HDL-C, TG and non-HDL-C (each 1-mmol/l increase). For these continuous baseline factors, the coefficients represent the percentage change associated with a one unit increase with the baseline factor. Factors for inclusion in the final model were identified using a backward selection process, removing factors one-at-a-time until all remaining factors were significant at 5% levels, ‡Odds ratio by logistic regression analysis; §Analyses based on transformed data, using normal scores rank-transformations for TG and hsCRP; #Although age was significant in the continuos model, it was no longer significant in the categorical model, possibly due to a loss of power in the dichotomous classification (<65 and ≥65years). Model robustness was assessed by comparison of results with a model that included MetS (2). ¶P<0.001; ║P<0.010; #P<0.05; NS=not significant (P>0.05). Conventional unit conversion factors: To convert cholesterol to mg/dl, divide by 0.0259; TG to mg/dl, divide by 0.0113; Apo to mg/dL, divide by 0.01; hsCRP to mg/l, divide by 9.524. Figure S1 . Multivariable association of categorical factors with the percent change from baseline in triglycerides (A), ApolipoproteinA-I (B) and hsCRP (C). Percent change for A and C are based on medians due to non-normal distribution. Pvalues (*p<0.05, **p<0.01,***p<0.001) correspond to the significance of marked (*) category compared with lowest category for the variable. BL=baseline.
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